2021
DOI: 10.1016/j.euo.2019.04.004
|View full text |Cite
|
Sign up to set email alerts
|

Gender Disparity in Cystectomy Postoperative Outcomes: Propensity Score Analysis of the National Surgical Quality Improvement Program Database

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
2
1
1
1

Citation Types

0
15
0

Year Published

2021
2021
2024
2024

Publication Types

Select...
8

Relationship

1
7

Authors

Journals

citations
Cited by 20 publications
(15 citation statements)
references
References 30 publications
0
15
0
Order By: Relevance
“…As one of the first symptoms of bladder cancer, hematuria may be misinterpreted in females as part of a urinary tract infection, thus resulting in a prolonged time between symptoms and diagnosis (22,23). Aside from that, differences in hormonal and genetic factors, tumor biology, smoking habits, and occupational risk factors as well as postoperative complication rates have been investigated (8,12,24). Moreover, women were more likely to present with squamous cell carcinoma, which was associated with a worse oncologic outcome (20,25,26).…”
Section: Gender Differences In Oncological Outcomesmentioning
confidence: 99%
See 1 more Smart Citation
“…As one of the first symptoms of bladder cancer, hematuria may be misinterpreted in females as part of a urinary tract infection, thus resulting in a prolonged time between symptoms and diagnosis (22,23). Aside from that, differences in hormonal and genetic factors, tumor biology, smoking habits, and occupational risk factors as well as postoperative complication rates have been investigated (8,12,24). Moreover, women were more likely to present with squamous cell carcinoma, which was associated with a worse oncologic outcome (20,25,26).…”
Section: Gender Differences In Oncological Outcomesmentioning
confidence: 99%
“…The main concern of organ-preserving RC is its oncological safety. Several studies demonstrated the technical feasibility of ROPRC without compromising oncological outcomes compared to standard RC (24,29). However, due to a lack of high-quality data, there is no recommendation for ROPRC as a standard alternative to standard RC for women (2,29).…”
Section: Oncological Safety Of Roprcmentioning
confidence: 99%
“…Though the prevalence of bladder cancer is three to four times lower in females, which is reflected in the number of cystectomies for males and females in the NIS data, female patients appear to have worse survival when matched with male patients of the same stage, particularly with advanced stage disease [17,18]. Previous studies show that women tend to have greater delays in referral to a urologist and to RC, present more often with advanced disease, and have worse survival outcomes [18][19][20]. Postoperative outcomes for females after ORC have a similarly poor trend, with greater complications including longer operative times, surgical site infections, blood transfusion requirements, longer length of stay, and higher readmission rate [16,20].…”
Section: Commentmentioning
confidence: 99%
“…Previous studies show that women tend to have greater delays in referral to a urologist and to RC, present more often with advanced disease, and have worse survival outcomes [18][19][20]. Postoperative outcomes for females after ORC have a similarly poor trend, with greater complications including longer operative times, surgical site infections, blood transfusion requirements, longer length of stay, and higher readmission rate [16,20]. It is plausible that advanced disease and higher postoperative complication rates correlate to the nearly $2,000 higher cost of hospitalization for female patients undergoing RC.…”
Section: Commentmentioning
confidence: 99%
“…We conclude that there is no role for prophylactic oophorectomy at the time of RC for the prevention of future ovarian cancer. In addition, given the lack of occult ovarian metastasis/involvement at the time of RC, as well as established harms of BSO, a careful risk-benefit discussion should be had with patients [10,19 ▪▪ ].…”
Section: Ovarian Preservation and Sexual Functionmentioning
confidence: 99%